Man Group’s LeMaitre Vascular LMAT Stock Holding History

Man Group’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.82M	Buy	29,417 +1,030	+4%	+$106K	﹤0.01%	1401
2026 Q1	$3.1M	Buy	28,387 +9,978	+54%	+$951K	0.01%	1374
2025 Q4	$1.49M	Buy	+18,409	New	+$1.58M	﹤0.01%	1558
2023 Q3	–	Sell	-7,199	Closed	-$484K	–	2048
2023 Q2	$484K	Buy	+7,199	New	+$439K	﹤0.01%	1598
2023 Q1	–	Sell	-5,550	Closed	-$269K	–	1717
2022 Q4	$255K	Buy	5,550 +570	+11%	+$26.7K	﹤0.01%	1697
2022 Q3	$252K	Buy	+4,980	New	+$249K	﹤0.01%	1715
2022 Q2	–	Sell	-9,207	Closed	-$412K	–	1794
2022 Q1	$428K	Buy	+9,207	New	+$412K	﹤0.01%	1629
2021 Q3	–	Sell	-3,335	Closed	-$204K	–	2004
2021 Q2	$204K	Buy	+3,335	New	+$177K	﹤0.01%	1798
2020 Q1	–	Sell	-6,136	Closed	-$221K	–	1755
2019 Q4	$221K	Buy	+6,136	New	+$212K	﹤0.01%	1749
2018 Q4	–	Sell	-36,137	Closed	-$1.4M	–	2027
2018 Q3	$1.4M	Buy	36,137 +10,250	+40%	+$369K	0.01%	1536
2018 Q2	$866K	Buy	25,887 +17,324	+202%	+$616K	﹤0.01%	1652
2018 Q1	$310K	Buy	+8,563	New	+$297K	﹤0.01%	1818

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Man Group's LMAT Position: Q2 2026 in Review

Man Group increased its LeMaitre Vascular (LMAT) stake by 3.6% in Q2 2026, buying an estimated $106K and bringing the position to 29,417 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Man Group first reported a position in LMAT in Q1 2018 and has held it in 12 quarters since. The position peaked at $3.1M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Man Group held 29,417 shares of LeMaitre Vascular worth $2.82M as of Q2 2026.
Man Group bought 1,030 LeMaitre Vascular shares in Q2 2026, an estimated $106K.
LeMaitre Vascular made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1401 holding.
Man Group first reported a position in LeMaitre Vascular in Q1 2018 and has held it in 12 quarters since.
Man Group's LeMaitre Vascular position peaked at $3.1M in Q1 2026.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.